久日新材：2025年前三季度计提资产减值损失和信用减值损失合计1592.24万元

Group 1 - The company, Jiu Ri New Materials, announced a provision for impairment losses totaling 15.92 million yuan, impacting the total profit by the same amount for the first three quarters of 2025 [1] - The revenue composition for Jiu Ri New Materials in 2024 is as follows: 78.4% from light-curing materials, 21.29% from fine chemicals, 0.18% from electronic chemicals, and 0.13% from other businesses [1] - As of the report, the market capitalization of Jiu Ri New Materials is 4 billion yuan [1] Group 2 - The Chinese innovative drug sector has generated 80 billion USD in overseas licensing deals this year, indicating a robust secondary market for biopharmaceuticals [1] - There is a contrast between the hot secondary market and the cooling fundraising environment in the primary market for biopharmaceuticals [1]